91 -2 (76) 2025 - Talipov O.A., Xakimova G.G. - USE OF THE SENTINEL LYMPH NODE BIOPSY METHOD IN BREAST CANCER

USE OF THE SENTINEL LYMPH NODE BIOPSY METHOD IN BREAST CANCER

Talipov O.A. - Tashkent Pediatric Medical Institute, Tashkent city branch of the Republican specialized scientific and practical center of oncology and radiology

Xakimova G.G. - Tashkent Pediatric Medical Institute, Tashkent city branch of the Republican specialized scientific and practical center of oncology and radiology

Aminova M.P. - Tashkent city branch of the Republican specialized scientific and practical center of oncology and radiology

Almurodova D.M. - Tashkent city branch of the Republican specialized scientific and practical center of oncology and radiology, Tashkent Medical Academy

Tashmetov M.N. - Tashkent Pediatric Medical Institute, Tashkent city branch of the Republican specialized scientific and practical center of oncology and radiology

Salohiddinov H.A. - Tashkent Pediatric Medical Institute

Resume

The decisive prognostic products of breast cancer continue to be axillary lymph node metastases. Lymph node involvement (N-status) influence the effect of adjuvant therapy and surgery. Sentinel lymph node biopsy for breast cancer continues to be of increasing interest among researchers, as the consequences associated with sentinel lymph node biopsy and its pathological examination may continue to be debated.

Key words: breast cancer, sentinel lymph node, biopsy, adjuvant chemotherapy, neoadjuvant chemotherapy.

First page

490

Last page

498

For citation:Talipov O.A., Xakimova G.G., Aminova M.P., Almurodova D.M., Tashmetov M.N., Salohiddinov H.A. - USE OF THE SENTINEL LYMPH NODE BIOPSY METHOD IN BREAST CANCER//New Day in Medicine 2(76)2025 490-498 https://https://newdayworldmedicine.com/en/new_day_medicine/2-76-2025

List of References

  1. Каприн А.Д., Старинский В.В., Шахзадова А.О. "Клинические рекомендации "Рак гортани" 2024 г.
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. // CA Cancer J Clin. 2021;71:209-249. https://doi.org/10.3322/caac.21660
  3. Каприн А. Д., Старинский В. В., Шахзадова О.А. Состояние Онкологической Помощи Населению России В 2021 Году 2022; 236 стр.
  4. Грушина Т. И., Ткаченко Г. А. Психологический дистресс у больных раком молочной железы после различных видов противоопухолевого лечения // Опухоли женской репродуктивной системы. 2016;(12):56-62.
  5. Грушина Т. И., Ткаченко Г. А. Реабилитация при раке молочной железы: физиотерапия, фармакотерапия и психокоррекция 2017; 95 стр.
  6. Грушина Т. И., Ткаченко Г. А. Пособие для врачей о реабилитации больных раком молочной железы (этапы, методы и методики) // A guide for doctors on the rehabilitation 2020;3(22):3-34.
  7. Каприн А. Д., Зикиряходжаев А. Д. Онкопластическая хирургия молочной железы 2017; 312 стр.
  8. Босиева А.Р., Ермощенкова М.В., Зикиряходжаев А. Д. Органосохраняющие операции после неоадъювантной лекарственной терапии у больных раком молочной железы // Siberian journal of oncology. 2021;4(20):116-121.
  9. Рассказова Е.А., Зикиряходжаев А. Д. Органосохраняющие и онкопластические резекции при раке молочной железы. Современные тенденции // Онкология. Журнал им. П.А. Герцена. 2022;11(5):65-69.
  10. Рябчиков Д. А., Петровский А. В. Рак молочной железы 2023; 400 стр.
  11. Pessoa EC, Rodrigues JR, Pessoa CP, Vespoli HM and Uemura G: Axillary lymph node aspiration guided by ultrasound is effective as a method of predicting lymph node involvement in patients with breast cancer ? // Rev Bras Ginecol Obstet. 2014;36:118-123. (In Portuguese).
  12. Baruah BP, Goyal A, Young P, Douglas-Jones AG and Mansel RE: Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. // Br J Surg. 2010;97:680-683.
  13. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes Olmos R, Schultze Kool LJ. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. // Eur J Cancer. 2003;39:1068-1073. doi: 10.1016/S0959-8049(02)00748-7.
  14. van Roozendaal LM, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, et al: Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: A Dutch randomized controlled multicentre trial (BOOG 2013–08). BMC Cancer. 2017;17:459.
  15. Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ, Appleton CM, Zoberi I, Thomas MA, Gao F and Gillanders WE: Successful completion of the pilot phase of a randomized controlled trial comparing sentinel lymph node biopsy to no further axillary staging in patients with clinical T1-T2 N0 breast cancer and normal axillary ultrasound. // J Am Coll Surg. 2016;223:399-407.
  16. Gentilini O and Veronesi U: Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs. observation after axillary ultrasound. Breast. 2012;21:678-681.
  17. Wenjun Jia, Xiao Chen, Xinyu Wang, Jianzhong Zhang, Tong Tang, Jianing Shi; The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients. // Breast Care19 December 2023;18(6):473- 482. https://doi.org/10.1159/000532081
  18. Mathelin C, Lodi M. Narrative review of sentinel lymph node biopsy in breast cancer: a technique in constant evolution with still numerous unresolved questions. // Chin Clin Oncol 2021;10(2):20. doi: 10.21037/cco-20-207
  19. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. // Lancet Oncol 2007;8:881-8.
  20. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. // N Engl J Med 2003;349:546-53.

    file

    download